Comparison of 32P-postlabeling and HPLC-FD analysis of DNA adducts in rats acutely exposed to benzo(a)pyrene

Chemico-Biological Interactions

Volumn 104, Issue 1, 1997, Pages 41-54

  Godschalk, Roger W L ^a   Vermeer, Ingrid T M ^a   Kriek, Erik ^b   Floot, Ben ^b   Schilderman, Pauline A E L ^a   Moonen, Edwin J C ^a   Kleinjans, Jos C S ^a   Van Schooten, Frederik Jan ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

32P postlabeling; DNA adducts; HPLC; Polycyclic aromatic hydrocarbons

Indexed keywords

BENZO[A]PYRENE; PHOSPHORUS 32; POLYCYCLIC AROMATIC HYDROCARBON; 3 HYDROXYBENZO[A]PYRENE; 3-HYDROXYBENZO(A)PYRENE; BENZO(A)PYRENE DNA ADDUCT; BENZO(A)PYRENE-DNA ADDUCT; BENZO[A]PYRENE DERIVATIVE; CARCINOGEN; DNA; PHOSPHORUS;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA ADDUCT; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; LIVER; LUNG; MALE; NONHUMAN; RAT; URINARY EXCRETION; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; FLUORESCENCE; HEART MUSCLE; KINETICS; LEWIS RAT; METABOLISM; POLLUTANT; URINE;

ANIMALS; BENZO(A)PYRENE; BENZOPYRENES; CARCINOGENS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA; DNA ADDUCTS; ENVIRONMENTAL POLLUTANTS; FLUORESCENCE; KINETICS; LIVER; LUNG; MALE; MYOCARDIUM; PHOSPHORUS RADIOISOTOPES; POLYCYCLIC HYDROCARBONS, AROMATIC; RATS; RATS, INBRED LEW; URINE;

EID: 0030611195     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(97)03765-4     Document Type: Article

References (24)

1. M. Hall and P.L. Grover, Polycyclic aromatic hydrocarbons: metabolism, activation, tumor-initiation, in: C.S. Cooper and P.L. Grover (Eds.), Chemical carcinogenesis and mutagenesis, Raven Press, New York, vol. 1, 1990, pp. 327-372.
2. K. Hemminki, DNA adducts, mutations and cancer, Carcinogenesis, 14 (1993) 2007-2012.
3. N. Zanesi, P. Ferraro, S. Pavanello, D. Furlan and L. Celotti, Cytotoxic and mutagenic effects of anti-and syn-benzo(a)pyrene diol epoxide in human lymphocytes, Toxicol. In Vitro, 8 (1994) 1269-1275.
4. F.J. Van Schooten, E. Kriek, M.J.S.T. Steenwinkel, H.P.J.M. Noteborn, M.J.X. Hillebrand and F.E. Van Leeuwen, The binding efficiency of polyclonal and monoclonal antibodies to DNA modified with benzo(a)pyrene diol epoxide is dependent on the level of modification. Implications for quantitation of benzo(a)pyrene-DNA adducts in vivo, Carcinogenesis, 8 (1987) 1263-1269.
5. 32P-postlabelled nucleoside 3′,5′-biphosphate adducts by HPLC, in: D.H. Phillips, M. Castegnaro, and H. Bartsch (Eds.), Postlabeling methods for detection of DNA adducts, IARC scientific publications, no. 124, 1993, pp. 233-242.
6. 32P-postlabeled DNA adducts, Carcinogenesis, 14 (1993) 1343-1348.
7. K. Alexandrov, M. Rojas, O. Geneste, M. Castegnaro, A-M. Camus, S. Petruzzelli, C. Giuntini and H. Bartsch, An Improved fluorometric assay for dosimetry of benzo(a)pyrene diol epoxide DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity, Cancer Res., 52 (1992) 6248-6253.
8. M. Rojas, K. Alexandrov, C. Auburtin, A. Wastiaux-Denamur, L. Mayer, B. Mathieu, P. Sebastien and H. Bartsch, Anti-benzo(a)pyrene diolepoxide-DNA adduct levels in peripheral mononuclear cells from coke oven workers and the enhancing effect of smoking, Carcinogenesis, 16 (1995) 1373-1376.
9. 32P-postlabeling and ELISA, Carcinogenesis, 15 (1994) 557-560.
10. 32P-postlabeling test for structurally diverse DNA-adducts, Carcinogenesis, 7 (1986) 1543-1551.
11. 32P] GMP, Biochim. Biophys. Acta., 7 (1979) 1543-1551.
12. 32P-postlabeling assay after either 1-butanol extraction or nuclease P1 treatment, Cancer Lett., 45 (1989) 7-12.
13. F.J. Jongeneelen, R.P. Bos, R.B.M. Anzion, J.L.G. Theeuws and P.T. Henderson, Biological monitoring of polycyclic aromatic hydrocarbons in urine, Scand. J. Work Environ. Health, 12 (1986) 137-143.
14. J. Ross, G.B. Nelson, K.H. Wilson, J.R. Rabinowitz, A. Galati, G.D. Stoner, S. Nesnow and M.J. Mass, Adenomas induced by PAH in strain A/J mouse lung correlates with time integrated DNA adduct levels, Cancer Res., 55 (1995) 1039-1044.
15. M.F. Denissenko, A. Pao, M. Tang and G.P. Pfeifer, Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53, Science, 274 (1996) 430-432.
16. J. Ross, G. Nelson, A. Kligerman, G. Erexson, M. Bryant, R. Gupta and S. Nesnow, Formation and persistence of novel B[a]P adducts in rat lung and peripheral blood lymphocyte DNA, Cancer Res., 50 (1990) 5088-5094.
17. M.L. Tyndyk, M.A. Zabezhinski, V.J. Bykov, P.P. Dikun, L.A. Dymochka, O.B. Nepomnyasshaya, O.S. Yatsuk, V.B. Yermilov and A.J. Likhachev, Individual values of excretion of B[a]P metabolites and susceptibility to its carcinogenic effect in rats, Cancer Lett., 78 (1994) 163-170.
18. S. Nesnow, J. Ross, G. Nelson, K. Holden, G. Erexson, A. Kligerman and R.C. Gupta, Quantitative and temporal relationship between DNA adduct formation in target and surrogate tissues: implications for biomonitoring, Environ. Health Perspect., 101 (1993) 37-42.
19. M. Suh, F. Ariese, G.J. Small, R. Jankowiak, A. Hewer and D.H. Phillips, Formation and persistence of benzo(a)pyrene-DNA adducts in mouse epidermis in vivo: importance of adduct conformation, Carcinogenesis, 16 (1995) 2561-2569.
20. A. Izotti, S. De Flora, G.L. Petrilli, J. Gallagher, M. Rojas, K. Alexandrov, H. Bartsch and J. Lewtas, Cancer biomarkers in human atherosclerotic lesions: detection of DNA adducts, Cancer Epidemiol. Biomarkers and Prevent., 4 (1995) 105-110.
21. K. Alexandrov, M. Rojas, F.F. Kadlubar, N.P. Lang and H. Bartsch, Evidence of anti-benzo[a]pyrene diolepoxide-DNA adduct formation in human colon mucosa, Carcinogenesis, 17 (1996) 2081-2083.
22. S.X. Qu and N.H. Stacey, Formation and persistence of DNA adducts in different target tissues of rats after multiple administrations of benzo(a)pyrene, Carcinogenesis, 17 (1996) 53-59.
23. A.J. Likhachev, D.Sh. Beniahvili, V.J. Bykov, P.P. Dikun, M.L. Tyndyk, I.V. Savochkina, V.B. Yermilov and M.A. Zabezhinski, Biomarkers for individual susceptibility to carcinogenic agents: Excretion and carcinogenic risk of B[a]P metabolites, Environ. Health Perspect., 98 (1992) 211-214.56.
24. P.A. Schulte and F.P. Perera, Validation, in: P.A. Schulte and F.P. Perera (Eds.), Molecular Epidemiology: principles and practices, Academic Press, New York, 1993.